How often should RA patients with low or moderate disease activity be monitored?

How often should RA patients with low or moderate disease activity be monitored?

• A. Every 1-2 weeks
• B. Every 2-3 months
• C. Every 6 months
• D. Every 4-6 weeks

Answer: (B)

In rheumatoid arthritis, monitoring frequency is guided by disease activity within a treat-to-target approach: adjust therapy until disease activity is low or in remission, then monitor at intervals that reflect stability. For patients with low or moderate activity on stable DMARD therapy, checking in every 2–3 months is appropriate. This interval lets enough time pass to see whether inflammation and function are improving or staying controlled, while still allowing timely detection of any flare or the need to tweak treatment. It also provides regular opportunities to review safety, run necessary labs, and address adverse effects or adherence. More frequent visits (every 1–2 weeks or monthly) are typical when activity is high or therapy has just been changed, to optimize treatment quickly. Waiting as long as every 6 months risks missing a rise in activity or medication toxicity.

In rheumatoid arthritis, monitoring frequency is guided by disease activity within a treat-to-target approach: adjust therapy until disease activity is low or in remission, then monitor at intervals that reflect stability. For patients with low or moderate activity on stable DMARD therapy, checking in every 2–3 months is appropriate. This interval lets enough time pass to see whether inflammation and function are improving or staying controlled, while still allowing timely detection of any flare or the need to tweak treatment. It also provides regular opportunities to review safety, run necessary labs, and address adverse effects or adherence. More frequent visits (every 1–2 weeks or monthly) are typical when activity is high or therapy has just been changed, to optimize treatment quickly. Waiting as long as every 6 months risks missing a rise in activity or medication toxicity.